Nuvalent Balance Sheet Health
Financial Health criteria checks 5/6
Nuvalent has a total shareholder equity of $1.1B and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $1.2B and $67.7M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$1.17b |
| Equity | US$1.12b |
| Total liabilities | US$67.73m |
| Total assets | US$1.19b |
Recent financial health updates
We're Hopeful That Nuvalent (NASDAQ:NUVL) Will Use Its Cash Wisely
Nov 18
Nuvalent (NASDAQ:NUVL) Is In A Strong Position To Grow Its Business
Aug 05Here's Why We're Not Too Worried About Nuvalent's (NASDAQ:NUVL) Cash Burn Situation
Apr 22Recent updates
Nuvalent: A First Look
Jan 22Nuvalent: A Logical Acquisition Target
Jan 10Nuvalent: Steps Toward That Favorable Entry Point
Dec 07We're Hopeful That Nuvalent (NASDAQ:NUVL) Will Use Its Cash Wisely
Nov 18Nuvalent: Promising Data Keeps Validating Pipeline And Platform
Sep 23Nuvalent: Likely Approvals Coming Up Do Not Justify This Valuation
Sep 17Nuvalent (NASDAQ:NUVL) Is In A Strong Position To Grow Its Business
Aug 05Nuvalent: Making Precise Progress In Its Oncology Pipeline
Jun 24Nuvalent: NVL-655 Could Bring Blockbuster Potential
Jun 14Here's Why We're Not Too Worried About Nuvalent's (NASDAQ:NUVL) Cash Burn Situation
Apr 22Nuvalent: Pivotal NSCLC Programs Progressing With Additional Data In 2024
Feb 26Nuvalent GAAP EPS of -$0.38 beats by $0.03
Aug 10Financial Position Analysis
Short Term Liabilities: NUVL's short term assets ($1.2B) exceed its short term liabilities ($51.1M).
Long Term Liabilities: NUVL's short term assets ($1.2B) exceed its long term liabilities ($16.6M).
Debt to Equity History and Analysis
Debt Level: NUVL is debt free.
Reducing Debt: NUVL had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NUVL has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if NUVL has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/30 00:09 |
| End of Day Share Price | 2025/01/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nuvalent, Inc. is covered by 17 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Colleen Kusy | Baird |
| Peter Lawson | Barclays |
| Evan Seigerman | BMO Capital Markets Equity Research |